Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stayhealthy.com: Monitoring your wellness on the Web -- Ignore unavailable to you. Want to Upgrade?

To: OFW who wrote (855)	8/22/2000 11:43:42 AM
From: Madeleine Harrison	Respond to of 3785

By entering the arena of researchers, STAY opens the door to extensive number of clinical trials and other high-end uses. Perhaps someone else can expand on what doors this could open for STAY. Other than the eventual betterment of human health? To start with, how about additional and substantial revenues streams for Stayhealthy, Inc ?

To: OFW who wrote (855)	8/22/2000 11:44:38 AM
From: Eric Fader	Respond to of 3785

Right, Offie... any detractors of Stayhealthy (are there any? <g>) who might call calorie tracking, body comp analysis and the current emphasis on weight loss and fitness "fluffy" would be stopped dead in their tracks by the advance orders for the RT3 from researchers and scientists in 11 countries, without any advertising or promotion whatsoever. Of course, the fitness/weight loss market is dwarfed by the markets that Stay will be entering with its other devices that are still under development. The digital scale they're working on doesn't excite me, but the (eventually) forthcoming cardiac and respiratory devices do. And there's one other huge market that I believe Stay is targeting that hasn't yet been mentioned in a press release... ;-)

To: OFW who wrote (855)	8/22/2000 12:00:34 PM
From: Eric Fader	Respond to of 3785

Not sure exactly what the difference is between the RT3 and the CT1 - imagine it's in the range of precise activity data available to the researcher as opposed to merely the calorie burn data available to the consumer of the CT1. I think that's right. Johnny Sawada once told me that the basic CT1 accelerometer technology could be easily tweaked to provide other types of information, or to read out in different units of measurement. It probably wouldn't hurt for Stay to incorporate into its advertising for the CT1 (which won't appear for some time because I believe the thing is sold out through November just from advance orders) that it uses "the identical technology used by researchers all over the world in their scientific studies!!", or maybe something slightly less hyperbolic <g>.